Skip to Main Content

Paper Details

Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in <sup>11</sup>C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
18
2021
Author NameAffiliation
Bradley J StishMayo Clinic
Fabrice LucienMayo Clinic
Lance C PagliaroMayo Clinic
C Richard ChooMayo Clinic
Brian J DavisMayo Clinic
Brian A CostelloMayo Clinic
Thomas M PisanskyMayo Clinic
  • 1 - 7

Datasets

Release 1.2